Skip to main content

Peer Review reports

From: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial

Original Submission
2 Oct 2019 Submitted Original manuscript
11 Nov 2019 Reviewed Reviewer Report - Christopher R. Sudfeld
27 Dec 2019 Reviewed Reviewer Report - Rachel Marcus
25 Jan 2020 Author responded Author comments - Israel Molina
29 Jan 2020 Reviewed Reviewer Report - Christopher R. Sudfeld
2 Mar 2020 Reviewed Reviewer Report - Rachel Marcus
Resubmission - Version 2
25 Jan 2020 Submitted Manuscript version 2
Publishing
3 Mar 2020 Editorially accepted
15 Apr 2020 Article published 10.1186/s13063-020-4226-2

You can find further information about peer review here.

Back to article page